BSPM OTC
Biostar Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
-91.2% ▼
5Y CAGR: -51.8%
Gross Profit
$915K
-91.8% ▼
5Y CAGR: -57.3%
Operating Income
-$4M
+85.0% ▲
Net Income
-$6M
+77.3% ▲
EPS (Diluted)
$-2.50
+78.0% ▲
EBITDA
-$2M
+92.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $49M | $53M | $61M | $27M | $2M |
| YoY Growth | -46.4% | +6.9% | +16.5% | -55.8% | -91.2% |
| Cost of Revenue | $19M | $27M | $31M | $16M | $1M |
| Gross Profit | $30M | $26M | $30M | $11M | $915K |
| Gross Margin | 60.5% | 48.7% | 49.3% | 40.9% | 38.4% |
| R&D Expenses | $4M | $3M | $3M | $4M | $1M |
| SG&A Expenses | $34M | $23M | $26M | $13M | $4M |
| Operating Expenses | $42M | $25M | $32M | $35M | $4M |
| Operating Income | -$20M | $508K | -$1M | -$24M | -$4M |
| Operating Margin | -40.9% | 1.0% | -2.1% | -87.6% | -149.5% |
| Interest Expense | $84K | $367K | $155K | $284K | $206K |
| Income Before Tax | -$22M | $3M | $2M | -$24M | -$3M |
| Tax Expense | -$2M | $2M | -$3M | $1M | $3M |
| Net Income | -$20M | $809K | $5M | -$25M | -$6M |
| Net Margin | -40.5% | 1.5% | 7.9% | -92.6% | -239.0% |
| EPS (Diluted) | $-14.63 | $0.49 | $2.30 | $-11.36 | $-2.50 |
| EBITDA | -$20M | $6M | $5M | -$21M | -$2M |
| Shares Outstanding | 1M | 2M | 2M | 2M | 2M |